NCT01162005View on ClinicalTrials.gov

Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Nephrotic Syndrome
Interventions
DRUG

Tacrolimus

dosage : 0.1-0.2 mg/kg/day divided two target trough level : 5 - 10 ng/mL Total duration (tacrolimus) : 1 year

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Chong Kun Dang Pharmaceutical

INDUSTRY

lead

Seoul National University Hospital

OTHER